2BBBullish & Bearish
Aclaris Therapeutics, Inc. (ACRS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 9 out of 100.
Aclaris Therapeutics, Inc.’s current 2BB score is 9 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 20 | Weak |
| Quality | 80 | Very Strong |
| Risk | 54 | Moderate |
| Founded | 2012 |
| Employees | 71 |
| 52-week range | $1.39 – $5.69 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-24 | — | -0.1775 | — | $1.46M |
| 2026-11-04 | — | -0.1678 | — | $1.32M |
| 2026-08-12 | — | -0.1632 | — | $1.41M |
| 2026-05-06 | — | -0.1617 | — | $1.22M |